Pfizer Inc. (PFE) |
|
36.7 -0.05 (-0.14%)
|
01-17 17:30 |
|
Open: |
36.68 |
Pre. Close: |
36.75 |
|
High:
|
36.78 |
Low:
|
36.4 |
|
Volume:
|
33,009,360 |
Market Cap:
|
203,993M |
|
|
|
|
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Sutent, Xtandi, Xalkori, Inlyta, Braftovi + Mektovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Vfend, and Zithromax brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, and tick-borne encephalitis under the Prevnar 13/Prevenar 13 (pediatric/adult), FSME-IMMUN, Nimenrix, and Trumenba brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, Genotropin, and Refacto AF/Xyntha brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company and Astellas Pharma US, Inc.; a licensing agreement with Akcea Therapeutics, Inc; a strategic alliance with Verily Life Sciences LLC; collaboration agreements with Merck KGaA and Valneva SE; a clinical trial collaboration and supply agreement with IDEAYA Biosciences, Inc.; a material transfer and collaboration agreement with BioNTech SE; a clinical supply collaboration with Jiangsu Alphamab Biopharmaceuticals Co., Ltd; a research collaboration and license agreement with BioInvent International AB; and a multi-target drug discovery collaboration with Sosei Group Corporation. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
36.835 - 37.093 |
37.093 - 37.29 |
|
Low:
|
35.717 - 36.071 |
36.071 - 36.343 |
|
Close:
|
36.211 - 36.69 |
36.69 - 37.057 |
|
Technical analysis |
as of: 2021-01-15 4:44:10 PM |
|
Overall:
|
  |
| Stoxline posted a SELL today, upgraded from strong sell. Downward movement continues, but could change at any time. |
| Target: |
Six months: 46.66  One year: 49.31 |
| Support: |
Support1: 36.27 Support2: 30.18 |
| Resistance: |
Resistance1: 39.95 Resistance2: 42.22 |
| Pivot: |
37.00 |
| Moving Average: |
MA(5): 37.05 MA(20): 37.11
MA(100): 36.23 MA(250): 34.90 |
| MACD: |
MACD(12,26): -0.29 Signal(9): -0.24 |
| Stochastic oscillator: |
%K(14,3): 32.05 %D(3): 44.63 |
| RSI: |
RSI(14): 43.16 |
| 52-week: |
High: 43.08 Low: 26.45 Change(%): -4.1 |
| Average Vol(K): |
3-Month: 4694919 10-Days: 3416366 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.PFE has closed above bottom band by 22.5%. Bollinger Bands are 68.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to PFE's normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Fri, 15 Jan 2021
Pfizer Inc. stock outperforms market despite losses on the day - MarketWatch
Wed, 13 Jan 2021
Pfizer Inc. stock falls Wednesday, underperforms market - MarketWatch
Tue, 12 Jan 2021
Pfizer Drops After 2021 Earnings Forecast Trails Estimates - Bloomberg
Tue, 12 Jan 2021
Should You Really Invest in Pfizer Stock in 2021? - The Motley Fool
Mon, 11 Jan 2021
Pfizer Inc. stock outperforms market on strong trading day - MarketWatch
Mon, 11 Jan 2021
Pfizer Inc. (PFE) Rises 1.72% for January 11 - Equities.com
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Outperform |
| Return on Equity: |
Neutral |
Debt to Equity: |
Outperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE |
| Sector: Healthcare |
| Industry: Drug Manufacturers General |
| Shares Out. (M) |
5,560 |
| Shares Float (M) |
5,550 |
|
% Held by Insiders
|
0.05 |
|
% Held by Institutions
|
69.90 |
|
Shares Short (K)
|
63,140 |
|
Shares Short P. Month (K)
|
66,530 |
Stock Financials |
|
EPS
|
1.540 |
|
EPS Est This Year
|
2.560 |
|
EPS Est Next Year
|
2.760 |
|
Book Value (p.s.)
|
11.740 |
|
Profit Margin
|
17.85 |
|
Operating Margin
|
29.24 |
|
Return on Assets (ttm)
|
5.1 |
|
Return on Equity (ttm)
|
13.3 |
|
Qtrly Rev. Growth
|
-4.3 |
|
Gross Profit (p.s.)
|
7.507 |
|
Sales Per Share
|
8.750 |
|
EBITDA (p.s.)
|
3.475 |
|
Qtrly Earnings Growth
|
-71.40 |
|
Operating Cash Flow (M)
|
12,550 |
|
Levered Free Cash Flow (M)
|
-655 |
Stock Valuations |
|
PE Ratio
|
23.83 |
|
PEG Ratio
|
5.26 |
|
Price to Book value
|
3.13 |
|
Price to Sales
|
4.19 |
|
Price to Cash Flow
|
16.26 |
Stock Dividends |
|
Dividend
|
1.500 |
|
Forward Dividend
|
1.560 |
|
Dividend Yield
|
0.04 |
|
Dividend Pay Date
|
2021-03-04 |
|
Ex-Dividend Date
|
2021-01-27 |
|
7 Binary Options
|
|
Your Ad Here
|
|
